Chinese Medicine Treatment on Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation / 中国结合医学杂志
Chinese journal of integrative medicine
; (12): 324-329, 2020.
Article
in En
| WPRIM
| ID: wpr-827453
Responsible library:
WPRO
ABSTRACT
Graft-versus-host disease (GVHD) is the most common complication after allogeneic hematopoietic stem cell transplantation, and also an important factor affecting the survival and quality of life in patients after transplantation. Currently, immunosuppressive therapy is commonly used for GVHD, but the curative effect is not ideal. How to effectively prevent and treat GVHD is one of the difficulties to be solved urgently in the field of transplantation. In this paper, we summarize the latest progress in pathogenesis, prevention and treatment of GVHD with Chinese medicine (CM). We hope it will provide ideas and methods for exploring the mechanism and establishing a new comprehensive therapy for GVHD with CM.
Key words
Full text:
1
Database:
WPRIM
Main subject:
Quality of Life
/
Hematopoietic Stem Cell Transplantation
/
Drug Therapy
/
Allografts
/
Graft vs Host Disease
/
Medicine, Chinese Traditional
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Chinese journal of integrative medicine
Year:
2020
Type:
Article